FDA gains power to force product recalls

The FDA has issued formal instructions outlining the circumstances and procedures under which it may now compel the removal of cosmetic products from the market—a capability established by the Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022. The document, titled Questions and Answers Regarding Mandatory Cosmetics Recalls, appeared in the Federal Register on October 23, solidifying an earlier draft released in December 2023. The agency noted that seven public submissions were submitted, all of which it characterized as “broadly supportive,” and adopted the final version without material alterations.

New Mandatory Recall Powers

Until now, cosmetic recalls in the U.S. relied on manufacturer cooperation, with the FDA lacking enforcement authority. MoCRA altered this dynamic, granting the agency the power to mandate removals when necessary. While voluntary recalls remain the standard approach, the new framework establishes a formal process for rare cases where companies fail to act.

Cosmetic chemist Kelly Dobos clarifies that the guidance creates a safety net for situations where a firm resists taking action, though such interventions are expected to be uncommon.

To justify a mandatory recall, the FDA must determine there is a credible risk that a product is either adulterated or improperly labeled, and that its use poses a significant threat to health or life.

Read Also: Founder Helps Women Preserve Hair, Identity During Chemo Recovery

How the Recall Process Works

A product may be classified as adulterated if it includes dangerous ingredients, was produced under unsanitary conditions, contains unauthorized color additives, or lacks sufficient safety validation. The FDA evaluates such determinations using evidence such as inspection reports, laboratory findings, adverse event documentation, and consumer complaints.

The manufacturer is first given an opportunity to voluntarily halt distribution and initiate a recall. Should the company disregard the request or fail to comply within the specified timeframe, the FDA may issue an immediate order to cease sales. Following this, the firm is granted a 10-day window for an informal hearing.

Only the FDA Commissioner possesses the authority to issue recall mandates, and this responsibility cannot be delegated. In cases of mandatory action, the agency commits to releasing a public statement identifying the affected product, detailing associated risks, and, when feasible, distinguishing unaffected alternatives.

Consumer Safeguards

The guidance carries no legal force but represents the FDA’s current position. The complete document is accessible on the FDA’s official site, ensuring transparency regarding cosmetic safety standards.